Agalloco & Associates Inc., 22 Carriage Trail, Belle Mead, NJ 08502
PDA J Pharm Sci Technol. 2021 Sep-Oct;75(5):458-464. doi: 10.5731/pdajpst.2020.011478. Epub 2021 Feb 19.
Sterilization validation practices in the United States rely heavily on the destruction of microorganisms to establish that sufficient lethality has been delivered. The objective in many instances is demonstration of the poorly defined attainment of "overkill" throughout the load. The complete destruction of resistant spore formers is assumed to support the attainment of a minimum probability of a nonsterile unit (PNSU). In reality, the absence of recoverable microorganisms in sterilization cycle development and validation does not allow for accurate PNSU determination. This article outlines how a strategy inspired by that used for ISO 11137-2, VD, with positive results can be used to fully support sterilization cycle efficacy. This article is intended to spark interest in a potentially novel approach to sterilization cycle development and can be refined once sufficient experience has been gained with it.
美国的灭菌验证实践在很大程度上依赖于微生物的破坏,以确定已达到足够的致死率。在许多情况下,目标是证明整个负载中“过杀”的程度定义不佳。完全破坏抗性孢子形成体被认为支持达到最小无菌单位概率(PNSU)。实际上,在灭菌周期开发和验证过程中没有可恢复的微生物,无法准确确定 PNSU。本文概述了如何借鉴 ISO 11137-2、VD 中使用的策略,并取得积极成果,以充分支持灭菌周期效果。本文旨在激发人们对灭菌周期开发的潜在新方法的兴趣,并在获得足够经验后对其进行改进。